Victory Capital Management
ICCC icon

Victory Capital Management’s ImmuCell ICCC Stock Holding History

Victory Capital Management’s Portfolio ICCC Stock Details ICCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,074
Closed -$8K – 2850
2020
Q1 		$8K Buy
+2,074
New +$10.2K ﹤0.01% 3368
2019
Q4 		– Sell
-1,077
Closed -$6K – 2918
2019
Q3 		$6K Buy
+1,077
New +$6.3K ﹤0.01% 3411

Other funds holding ICCC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OMC
Overbrook Management Corp New York $663M AUM 35.04% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
SFS
Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management's ICCC Position: Q2 2020 in Review

Victory Capital Management sold out of ImmuCell (ICCC) in Q2 2020, closing a stake of 2,074 shares — an estimated $8K sold.

Victory Capital Management first reported a position in ICCC in Q3 2019 and held it in 2 quarters. The position peaked at $8K in Q1 2020. 24 funds tracked by Wall St. Rank hold ICCC as of Q2 2020.

  • Victory Capital Management reported no remaining ImmuCell position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 2,074 ImmuCell shares in Q2 2020, an estimated $8K.
  • Victory Capital Management first reported a position in ImmuCell in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's ImmuCell position peaked at $8K in Q1 2020.
  • 24 funds tracked by Wall St. Rank held ImmuCell as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.